Education
About Us
Working with TipRanks
Follow Us
Astec Lifesciences Limited (IN:ASTEC)
:ASTEC
Total Valuation
Astec Lifesciences Limited has a market cap or net worth of ₹20.39B. The enterprise value is ₹12.24B.
Market Cap₹20.39B
Enterprise Value₹12.24B
Share Statistics
Astec Lifesciences Limited has 22,413,383 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding22,413,383
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Astec Lifesciences Limited’s return on equity (ROE) is -0.57 and return on invested capital (ROIC) is 3.07%.
Return on Equity (ROE)-0.57
Return on Assets (ROA)-0.15
Return on Invested Capital (ROIC)3.07%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee6.29M
Profits Per Employee-2.22M
Employee Count606
Asset Turnover0.43
Inventory Turnover1.86
Valuation Ratios
The current PE Ratio of Astec Lifesciences Limited is -10.63. Astec Lifesciences Limited’s PEG ratio is -0.06.
PE Ratio-10.63
PS Ratio0.00
PB Ratio6.10
Price to Fair Value6.10
Price to FCF-47.38
Price to Operating Cash Flow-170.49
PEG Ratio-0.06
Income Statement
In the last 12 months, Astec Lifesciences Limited had revenue of 3.81B and earned -1.35B in profits. Earnings per share was -68.71.
Revenue3.81B
Gross Profit843.67M
Operating Income232.63M
Pretax Income-1.41B
Net Income-1.35B
EBITDA-662.07M
Earnings Per Share (EPS)-68.71
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Astec Lifesciences Limited pays an annual dividend of ₹1.5, resulting in a dividend yield of 0.16%
Dividend Per Share₹1.5
Dividend Yield0.16%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.92
52-Week Price Change-32.22%
50-Day Moving Average761.39
200-Day Moving Average909.08
Relative Strength Index (RSI)62.25
Average Volume (3m)6.98K
Important Dates
Astec Lifesciences Limited upcoming earnings date is Jul 23, 2025, TBA (Confirmed).
Last Earnings DateApr 23, 2025
Next Earnings DateJul 23, 2025
Ex-Dividend DateJul 21, 2023
Financial Position
Astec Lifesciences Limited as a current ratio of 0.93, with Debt / Equity ratio of 236.23%
Current Ratio0.93
Quick Ratio0.50
Debt to Market Cap0.39
Net Debt to EBITDA-8.34
Interest Coverage Ratio0.63
Taxes
In the past 12 months, Astec Lifesciences Limited has paid 62.77M in taxes.
Income Tax62.77M
Effective Tax Rate-0.04
Enterprise Valuation
Astec Lifesciences Limited EV to EBITDA ratio is -29.96, with an EV/FCF ratio of -65.64.
EV to Sales5.20
EV to EBITDA-29.96
EV to Free Cash Flow-65.64
EV to Operating Cash Flow-236.20
Balance Sheet
Astec Lifesciences Limited has ₹27.05M in cash and marketable securities with ₹5.55B in debt, giving a net cash position of ₹5.52B billion.
Cash & Marketable Securities₹27.05M
Total Debt₹5.55B
Net Cash₹5.52B
Net Cash Per Share₹246.21
Tangible Book Value Per Share₹107.88
Margins
Gross margin is 22.13%, with operating margin of 6.10%, and net profit margin of -35.34%.
Gross Margin22.13%
Operating Margin6.10%
Pretax Margin-36.98%
Net Profit Margin-35.34%
EBITDA Margin-17.36%
EBIT Margin-28.83%
Analyst Forecast
The average price target for Astec Lifesciences Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-16.78%
EPS Growth Forecast-187.09%